About this trial

The purpose of this multi-phase research study is to understand how consultation of cancer care with a geriatrician can best improve outcomes for older adults with gastrointestinal malignancies.

Eligibility criteria

Qualifiers

Patients who are age 70+ at time of initial consult at DF/BWCC

Diagnosed with a gastrointestinal cancer, including: cancers of the esophagus, stomach, pancreas, liver, bile duct, ampulla, colon, rectum, or anus, as well as neuroendocrine tumors.

Continuing care at DF/BWCC beyond initial consult visit

English and Spanish-speaking

Disqualifiers

Patients less than age 70 at time of initial consultation appointment with DF/BWCC.

Patients who are not continuing care at DF/BWCC beyond first consult visit.

Not proficient in English or Spanish

Patient who are not considered appropriate for enrollment due to complex medical, social, or other situation as determined by their primary oncology team.

Trial design

Treatments tested in this trial

  • Phase 2 Intervention - Geriatric Co-Management

Treatment groups

257 Participants
are divided into 2 treatment groups

Locations

1
Dana-Farber Cancer Institute02215, BostonMassachusetts, United States

Sponsors and collaborators

Dana-Farber Cancer Institute

Lead sponsor